Table 1.
Characteristic | No. of patients (%) |
---|---|
Age at diagnosis, years (range) | 53.25 (29–80) |
Female | 33 (46.5) |
Race/ethnicity | |
White | 50 (70.4) |
Black | 10 (14.1) |
Hispanic | 9 (12.7) |
Other | 2 (2.8) |
Colorectal cancer site | |
Right colon | 22 (31.0) |
Left colon | 19 (26.8) |
Rectum | 30 (42.3) |
Synchronous CRC | 3 (4.2) |
Tumor stage | |
Tis/I | 8 (11.3) |
II | 12 (16.9) |
III | 19 (26.8) |
IV | 32 (45.1) |
Neoadjuvant treatment | 23 (32.4) |
Tumor histology | |
Poorly differentiated | 16 (22.5) |
Mucinous | 8 (11.3) |
Family history | |
Revised Bethesda | 37 (52.1) |
Amsterdam I | 2 (2.8) |
FDR with CRC | 13 (18.3) |
PREMM1,2,6 score >5% | 29 (40.8) |
Genetic counseling | 55 (77.5) |
Germline testing | 21 (29.6) |
CRC, colorectal cancer; FDR, first-degree relative.